News Archive
Quite an "only in Massachusetts" moment. Patriots owner Robert Kraft and leaders of Raytheon, Suffolk Construction and Putnam Investments have all filed letters in support of an anti-trust agreement that would not normally see the light of day before a judge approves the deal. The opposition includes public health professors, a group of top economists and politicians battling Attorney General Martha Coakley in the governor's race. This show of force is weighing in on a deal Coakley negotiated with Partners HealthCare. It would let the state's largest hospital network expand its market power, but with constraints, some of which would last for 10 years (Bebinger, 7/24).
Dutch biotechnology company Mucosis B.V. announced today that it has entered into a collaboration agreement with the global health nonprofit organization PATH to pursue the use of the company's Mimopath technology in oral vaccines to prevent and treat severe diarrhea.
Alector, a privately held biotechnology company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegeneration, today announced the initiation of its Phase 1 trial called INFRONT, which is evaluating AL001, the company's product candidate for the treatment of a genetically-defined sub-population of patients with frontotemporal dementia.
The Department of Veterans Affairs has selected the construction contractor to build a research office building at the Pittsburgh VA Medical Center on University Drive.
› Verified 7 days ago